Title:
Ｎ−フェニル−カルボキサミド誘導体およびＢ型肝炎を治療するための医薬品としてのその使用
Document Type and Number:
Japanese Patent JP6419155
Kind Code:
B2
Abstract:
The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
Inventors:
Van Dick, Cohen
Ashe, Garwin Yvonne Paul
Last, Stephan Julian
La Boisson, Pierre Jean-Mari Bernard
Ashe, Garwin Yvonne Paul
Last, Stephan Julian
La Boisson, Pierre Jean-Mari Bernard
Application Number:
JP2016505809A
Publication Date:
November 07, 2018
Filing Date:
April 02, 2014
Export Citation:
Assignee:
Janssen Sciences Ireland Ireland
International Classes:
C07D207/48; A61K31/40; A61K31/4025; A61K31/403; A61K31/404; A61K31/407; A61P1/16; A61P31/20; A61P43/00; C07D209/42; C07D209/52; C07D405/12; C07D409/12; C07D487/08; C07D491/107
Other References:
Liu, G. et al.,J. Med. Chem.,2012年,vol.55,p.3250-3260
Attorney, Agent or Firm:
Hiroshi Kobayashi
Junko Kobayashi
Norio Omori
Yasuhito Suzuki
Junko Kobayashi
Norio Omori
Yasuhito Suzuki